Wellington Management Group LLP Athira Pharma, Inc. Transaction History

Wellington Management Group LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$8.96 - $13.51 $50,749 - $76,520	5,664 Added 5.14%	115,900 $1.57 Million
Q4 2021 Feb 11, 2022	BUY	$9.17 - $16.39 $1.01 Million - $1.81 Million	110,236 New	110,236 $1.44 Million
Q4 2020 Feb 12, 2021	SELL	$16.48 - $34.3 $415,394 - $864,565	-25,206 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $403,800 - $465,302	25,206 New	25,206 $465,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $25M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.